Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results
Risankizumab治疗中重度斑块状银屑病的长期安全性和有效性：LIMMitless III期开放标签扩展试验的最终结果
期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-025-00964-6
Papp, Kim A; Lebwohl, Mark G; Puig, Lluís; Ohtsuki, Mamitaro; Beissert, Stefan; Gooderham, Melinda; Amin, Ahmad Z; Wu, Tianshuang; Rubant, Simone; Bialik, Brenton; Ashley, Doug; Soliman, Ahmed M; Chen, Michael M; Blauvelt, Andrew
